Reshaping of Global Policy by COVID: Implications for Market Access

The COVID-19 pandemic has upended daily lives around the globe and has also created new challenges for life sciences companies and governments alike in their mission to ensure effective treatments are both developed and available to patients in need. At a time of uncertainty, governments around the world have instituted policy changes intended to mitigate the impact of the coronavirus that could have long-lasting impacts for the global health sector. Find out more here.

(Source: Steve Edgar, Senior Manager, Global Market Access; DRG; 12/9/20)